Skip to main content

Maven Bio Seeks Buyer for Label-Free Detection, Imaging Technology

NEW YORK (GenomeWeb News) – Maven Biotechnologies is seeking a buyer for its label-free detection and imaging technology.

The technology called LFIRE is a method for detection and ellipsometry reflection and provides enhanced, high-content, label-free detection and imaging and high-capacity screening. Today, BioMed Transition Partners announced Maven Bio has retained its services to help find a buyer for the technology.

Monrovia, Calif.-based life science tools company Maven Bio said on its website that LFIRE measures biomolecular interactions in a microarray or well-plate format, and added that as a real-time system, it provides information about a sample before and after equilibrium, which is required "for increasing the dynamic range of concentration measurements, optimizing biological assays, and analyzing kinetic activity critical to drug research."

The system, which can be used for molecular and cell-based assays, is currently in the optimization stage of development and is near market commercialization for research applications, BioMed Transition said.

The technology has applications in research, development, and quality control in academic laboratories, pharmaceutical companies, clinical diagnostics, point-of-care diagnostics, and the animal health and food and beverage markets, the New York-based biomedical management advisory firm added. BioMed Transition is an affiliate of The Channel Group, an investment, development, and management firm.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.